Chitosan gold nanoparticles induce different ROS-dependent cell death modalities in leukemic cells.

Nanotechnology proposes the use of gold nanoparticles (AuNPs) for drug delivery, diagnosis, and treatment of cancer. Leukemia is a type of hematopoietic cancer that results from the malignant transformation of white blood cells.

https://www.ncbi.nlm.nih.gov/pubmed/31564872